Amir et al. (55) demonstrated co-dependence between ASPSCR1-TFE3 and Valosin-containing protein (VCP) in cancer cell proliferation and tumorigenesis in ASPS mouse models, suggesting VCP as a specific cofactor and potential novel therapeutic target. Here, TFE3 is linked to alveolar soft part sarcoma.